COVID-19: Revisiting Shareholder Rights Plans

Download IconDownload Print IconPrint

COVID-19: Revisiting Shareholder Rights Plans

Publication

Related Documents

Contributors

Read more in our Coronavirus (COVID-19) Center.

View All

Related Solutions

Helping companies develop and execute the legal and operational plans needed to navigate challenges related to the coronavirus (COVID-19).
WilmerHale lawyers have decades of experience advising public and private companies in all aspects of mergers and acquisitions.

The turmoil in US equity markets created by the COVID-19 pandemic has resulted in many companies facing depressed stock prices, leaving them vulnerable to unsolicited acquisition proposals or activist activity, which has led to heightened interest in shareholder rights plans (also known as “poison pills”). WilmerHale’s Mergers and Acquisitions practice has prepared a high-level overview of the advantages, disadvantages, prevalence and operation of rights plans.

Contributors